Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Prepaid Assets (2022 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Prepaid Assets for 4 consecutive years, with $15.4 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 26.42% to $15.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.4 million through Dec 2025, down 26.42% year-over-year, with the annual reading at $15.4 million for FY2025, 26.42% down from the prior year.
  • Prepaid Assets for Q4 2025 was $15.4 million at Phathom Pharmaceuticals, up from $13.2 million in the prior quarter.
  • The five-year high for Prepaid Assets was $20.9 million in Q4 2024, with the low at $975000.0 in Q3 2022.
  • Average Prepaid Assets over 4 years is $11.3 million, with a median of $13.0 million recorded in 2023.
  • The sharpest move saw Prepaid Assets soared 1226.97% in 2023, then dropped 26.42% in 2025.
  • Over 4 years, Prepaid Assets stood at $5.1 million in 2022, then skyrocketed by 157.34% to $13.2 million in 2023, then skyrocketed by 58.15% to $20.9 million in 2024, then decreased by 26.42% to $15.4 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $15.4 million, $13.2 million, and $14.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.